InvestorsHub Logo
Followers 78
Posts 11422
Boards Moderated 0
Alias Born 04/03/2014

Re: None

Monday, 09/14/2020 1:48:29 PM

Monday, September 14, 2020 1:48:29 PM

Post# of 233238
So NP did not want to do trial with Remdisvir.

Big boys play together and divide the share. NP thought he is smart but he is not smart enough to know that he is not smart.

They will get EUA and LERO will conduct another trial.

“Eli Lilly (LLY) and partner Incyte (INCY) early Monday released positive initial data of their coronavirus treatment when combined with Gilead Sciences' remdesivir. Eli Lilly stock and Incyte stock rose on the news.

The companies said they will seek emergency use authorization with the U.S. Food and Drug Administration and other regulatory agencies for their drug, baricitinib, as a treatment for hospitalized Covid-19 patients.”
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News